Loading company…
Sitka Biopharma develops a polymer-based drug delivery technology that helps taxane drugs treat bladder cancer.
Founded in 2013 and based in British Columbia, Canada, Sitka Biopharma Inc. develops a polymer-based drug delivery technology for bladder cancer. The formulation lets taxane drugs adhere to and penetrate the bladder wall, improving drug absorption. It is classified at the Seed stage.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in